Skip to main content
Core Technology

Our therapy is safe

  • Ethically sourced from healthy volunteers, allogeneic MSCs are introduced with therapeutic genes (cargo) one time to minimize risks associated with genetic engineering.
  • A safety gene is introduced along with therapeutic genes to ensure quality control and limit the occurrence of severe adverse events

Our therapy is effective

  • Unlike conventional gene therapy, which struggles to deliver genes to the site of interest, our approach exploits the tumor-homing property of MSCs to facilitate gene delivery, maximizing both the efficiency and efficacy of our gene therapy.

Our product is scalable

  • Thanks to the proliferation capability of MSCs, we can easily scale production by orders of magnitude, creating a large quantity of homogeneous cells with the same therapeutic properties as the starting batch.